<p>Activation of Nrf2 Signaling by Apelin Attenuates Renal Ischemia Reperfusion Injury in Diabetic Rats</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of Nrf2 Signaling by Apelin Attenuates Renal Ischemia Reperfusion Injury in Diabetic Rats

Published:2020-06 Issue: Volume:Volume 13 Page:2169-2177
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Zhang Xiaobo,Zhu Ying,Zhou Ying,Fei Bingru

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference35 articles.

1. Bone Marrow Stem Cell as a Potential Treatment for Diabetes

2. Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox

3. Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease

4. A systematic review and meta-analysis on the efficacy and safety of traditional Chinese patent medicine Jinqi Jiangtang Tablet in the treatment of type 2 diabetes

5. Diabetes Mellitus: Incidence, Prevalence, Survivorship, and Causes of Death in Rochester, Minnesota, 1945–1970

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apelinergic system in acute kidney injury: Mechanistic insights and therapeutic potential;Life Sciences;2024-11

2. Effects of apelin on neonatal brain neurogenesis in L-NAME-induced maternal preeclampsia;Scientific Reports;2024-08-20

3. Apelin is Peptide Increasing Tolerance of Organs and Cells to Hypoxia and Reoxygenation. The Signaling Mechanism;International Journal of Peptide Research and Therapeutics;2024-03-14

4. LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin/Nrf2/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea;Epigenetics;2024-01-17

5. Apelin is a peptide increasing tolerance of organs and cells to ischemia and reperfusion. The molecular mechanism (the review);The Siberian Journal of Clinical and Experimental Medicine;2024-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3